Funding for this research was provided by:
Kaken Pharmaceutical (23K15585)
Saitama Medical University
Article History
Received: 18 August 2025
Accepted: 15 October 2025
First Online: 25 October 2025
Declarations
:
: Daisuke Sakamaki and Kazutoshi Onitsuka: None. Yusuke Mazda holds 80% of non-public shares of OASIS Clinical Partners, Inc.